SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-006433
Filing Date
2024-02-22
Accepted
2024-02-22 17:28:33
Documents
1
Period of Report
2024-02-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1708640897.html 4  
1 FORM 4 wk-form4_1708640897.xml 4 6042
  Complete submission text file 0001628280-24-006433.txt   7506
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Issuer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CARIBOU BIOCIENCES, INC. 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address
O'Byrne Jason (Reporting) CIK: 0001871145 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40631 | Film No.: 24666271